JP2007001975A5 - - Google Patents

Download PDF

Info

Publication number
JP2007001975A5
JP2007001975A5 JP2006165170A JP2006165170A JP2007001975A5 JP 2007001975 A5 JP2007001975 A5 JP 2007001975A5 JP 2006165170 A JP2006165170 A JP 2006165170A JP 2006165170 A JP2006165170 A JP 2006165170A JP 2007001975 A5 JP2007001975 A5 JP 2007001975A5
Authority
JP
Japan
Prior art keywords
allergens
allergen
kits
peptide fragments
chimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006165170A
Other languages
English (en)
Other versions
JP5390742B2 (ja
JP2007001975A (ja
Filing date
Publication date
Priority claimed from US10/799,514 external-priority patent/US7923209B2/en
Application filed filed Critical
Publication of JP2007001975A publication Critical patent/JP2007001975A/ja
Publication of JP2007001975A5 publication Critical patent/JP2007001975A5/ja
Application granted granted Critical
Publication of JP5390742B2 publication Critical patent/JP5390742B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2007001975
 キメラアレルゲン
本願発明は、キメラアレルゲンタンパク質および連続する重複ペプチド断片を収容した一つ以上の容器を含む、診断用途に供される組成物とキットをさらに提供する。 キメラアレルゲンタンパク質およびペプチド断片は、様々なアレルゲン（例えば、第一のアレルゲンに由来するアレルゲンと、同じクラスに属する第二のアレルゲンに由来する他のアレルゲン(例えば、蜂毒、樺花粉、塵性ダニなど)）に由来するペプチドを含む。 このキットは、上述したアッセイで用いた、前出の一連の濃度の組成物、ポジティブコントロールおよびネガティブコントロールをさらに任意に含む。
Figure 2007001975
 アレルゲンを具備したキット
本願発明は、特定のアレルゲンタンパク質および連続する重複ペプチド断片を収容した一つ以上の容器を含む、診断用途に供されるキットをさらに提供する。 このキットは、上述したアッセイで用いた、前出の一連の濃度の組成物、ポジティブコントロールおよびネガティブコントロールをさらに任意に含む。
JP2006165170A 2003-03-14 2006-06-14 アレルゲンペプチド断片を含む組成物 Expired - Fee Related JP5390742B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45500403P 2003-03-14 2003-03-14
US60/455,004 2003-03-14
US10/799,514 2004-03-12
US10/799,514 US7923209B2 (en) 2003-03-14 2004-03-12 Allergen peptide fragments and use thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006506543A Division JP5389326B2 (ja) 2003-03-14 2004-03-15 アレルゲンペプチド断片およびその利用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011094277A Division JP2011201886A (ja) 2003-03-14 2011-04-20 アレルゲンペプチド断片を含む組成物

Publications (3)

Publication Number Publication Date
JP2007001975A JP2007001975A (ja) 2007-01-11
JP2007001975A5 true JP2007001975A5 (ja) 2010-05-13
JP5390742B2 JP5390742B2 (ja) 2014-01-15

Family

ID=33456828

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2006506543A Expired - Fee Related JP5389326B2 (ja) 2003-03-14 2004-03-15 アレルゲンペプチド断片およびその利用
JP2006165170A Expired - Fee Related JP5390742B2 (ja) 2003-03-14 2006-06-14 アレルゲンペプチド断片を含む組成物
JP2011094277A Pending JP2011201886A (ja) 2003-03-14 2011-04-20 アレルゲンペプチド断片を含む組成物
JP2013170083A Pending JP2013256520A (ja) 2003-03-14 2013-08-20 アレルゲンペプチド断片およびその利用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2006506543A Expired - Fee Related JP5389326B2 (ja) 2003-03-14 2004-03-15 アレルゲンペプチド断片およびその利用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011094277A Pending JP2011201886A (ja) 2003-03-14 2011-04-20 アレルゲンペプチド断片を含む組成物
JP2013170083A Pending JP2013256520A (ja) 2003-03-14 2013-08-20 アレルゲンペプチド断片およびその利用

Country Status (6)

Country Link
US (5) US7923209B2 (ja)
EP (4) EP1603591A2 (ja)
JP (4) JP5389326B2 (ja)
AU (2) AU2004220274B2 (ja)
CA (2) CA2759072A1 (ja)
WO (1) WO2004081028A2 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
JP2010505883A (ja) 2006-10-12 2010-02-25 ザ ユニバーシティー オブ クイーンズランド 免疫応答を調節するための組成物および方法
GB0710529D0 (en) * 2007-06-01 2007-07-11 Circassia Ltd Vaccine
ITMI20072421A1 (it) 2007-12-21 2009-06-22 Lofarma Spa Allergeni ed allergoidi da veleno d'api
CA2750705C (en) * 2009-02-09 2015-12-29 Anergis S.A. Contiguous overlapping peptides for treatment of birch pollen allergy
JP5728678B2 (ja) * 2009-03-26 2015-06-03 国立大学法人名古屋大学 アレルギー疾患を診断するための方法
GB201002559D0 (en) * 2010-02-15 2010-03-31 Circassia Ltd Birch peptides for vaccine
US9724271B2 (en) 2010-04-30 2017-08-08 Allovate, Llc Methods and articles for preventing or reducing risk of developing a hyperallergenic immune system
PT2563316T (pt) * 2010-04-30 2019-05-27 Allovate Llc Pasta de dentes para desensibilização alérgica através da mucosa oral
CA2816529A1 (en) 2010-11-01 2012-05-10 University Of Technology, Sydney Immune-modulating agents and uses therefor
EP2460824A1 (en) * 2010-12-01 2012-06-06 Biomay Ag Hypoallergenic polypeptides for the treatment of house dust mite allergy
AU2012277491B2 (en) 2011-06-27 2017-03-23 Anergis S.A. Contiguous overlapping peptides for treatment of ragweed pollen allergy
EP4324479A3 (en) 2012-08-21 2024-04-24 Sanofi Biotechnology Methods for treating or preventing asthma by administering an il-4r antagonist
RU2687164C2 (ru) * 2012-10-30 2019-05-07 Аравакс Пти Лтд Новые иммунотерапевтические молекулы и их применения
TWI633891B (zh) 2013-06-04 2018-09-01 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑以治療過敏及增強過敏原－特異之免疫療法的方法
AU2014276484B2 (en) * 2013-06-06 2018-01-25 Anergis S.A. Contiguous overlapping peptides for treatment of house dust mites allergy
TWI634900B (zh) 2013-07-11 2018-09-11 再生元醫藥公司 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
EP3046633A4 (en) 2013-09-19 2017-03-15 Allovate, LLC Toothpaste for delivering allergens to oral mucosa
EP3049098A4 (en) * 2013-09-25 2017-08-16 Aravax Pty Ltd Novel immunotherapeutic composition and uses thereof
PT3110848T (pt) 2014-09-24 2024-03-05 Regeneron Pharma Métodos para tratamento de infeção cutânea por administração de um antagonista do il-4r
EP3218412A1 (en) 2014-11-14 2017-09-20 Sanofi Biotechnology Methods for treating chronic sinusitis with nasal polyps by administering an il-4r antagonist
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
WO2017179025A1 (en) * 2016-04-15 2017-10-19 Alk-Abelló A/S Epitope polypeptides of ragweed pollen allergens
CA3035202A1 (en) 2016-09-01 2018-03-08 Regeneron Pharmaceuticals, Inc. Methods for preventing or treating allergy by administering an il-4r antagonist
WO2018057776A1 (en) 2016-09-22 2018-03-29 Regeneron Pharmaceuticals, Inc. Methods for treating severe atopic dermatitis by administering an il-4r inhibitor
TWI784988B (zh) 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
US11053309B2 (en) 2017-08-04 2021-07-06 Regeneron Pharmaceuticals, Inc. Methods for treating active eosinophilic esophagitis
US11034768B2 (en) 2017-10-30 2021-06-15 Sanofi Biotechnology Methods for treating or preventing asthma by administering an IL-4R antagonist
EP3793597A1 (en) 2018-05-13 2021-03-24 Regeneron Pharmaceuticals, Inc. Methods for treating atopic dermatitis by administering an il-4r inhibitor
US20200188511A1 (en) 2018-12-12 2020-06-18 Anergis S.A. Methods of improving efficacy of allergy vaccines
SG11202109002XA (en) 2019-03-21 2021-09-29 Regeneron Pharma Combination of il-4/il-13 pathway inhibitors and plasma cell ablation for treating allergy
IL289613B2 (en) 2019-08-05 2023-09-01 Regeneron Pharma IL-4R antagonist in combination with a scit regimen to increase immunotherapeutic efficacy and tolerability to a grass-specific allergen

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4473495A (en) * 1983-07-28 1984-09-25 Northwestern University Albumin-solubilized hymenoptera venoms for vaccine use
JP2993967B2 (ja) * 1987-06-17 1999-12-27 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダニアレルゲンのクローニング
JP2594123B2 (ja) 1987-09-12 1997-03-26 株式会社林原生物化学研究所 減感作剤
US5152980A (en) * 1988-05-19 1992-10-06 The Beth Israel Hospital Association Induction of tolerance to a foreign antigen IL-2 receptor-binding substances
US5124249A (en) * 1989-11-28 1992-06-23 Khan Rashid H Method for evaluating protection to bee venom
US5565338A (en) * 1990-06-04 1996-10-15 La Jolla Institute For Allergy And Immunology Suppressor T-cell hybridoma and production of allergen specific glycosylation inhibiting factor
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
IL105153A (en) 1992-03-25 1999-12-22 Immulogic Pharma Corp Therapeutic compositions comprising peptides derived from human t cell reactive feline protein
IT1254360B (it) 1992-05-11 1995-09-14 San Romanello Centro Fond Epitopi immunologicamente omologhi di hla e proteine del virus hiv.
US5582995A (en) 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
US6074673A (en) * 1996-04-22 2000-06-13 Guillen; Manuel Slow-release, self-absorbing, drug delivery system
AU9531698A (en) 1997-10-15 1999-05-03 Alk A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
EP1044019A1 (en) 1998-01-09 2000-10-18 Circassia Limited Methods and compositions for desensitisation
AU6039199A (en) * 1998-09-14 2000-04-03 Pan Pacific Pharmaceuticals, Inc. Useful properties of a bee venom protein and gene encoding same
FR2788698B1 (fr) 1999-01-27 2001-03-30 Commissariat Energie Atomique Peptides et proteines aptes a desensibiliser les sujets allergiques au venin d'abeille et compositions les contenant
US20030211510A1 (en) 1999-06-30 2003-11-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6780416B1 (en) 2000-02-18 2004-08-24 Ecole Polytechnique Federale De Lausanne Bee venom polypeptides and methods of use thereof
US20020193295A1 (en) 2001-05-04 2002-12-19 Emanuel Calenoff Immunogenic peptides and uses thereof
AU2003245729A1 (en) 2002-06-27 2004-01-19 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating a cytotoxic t lymphocyte immune response
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof

Similar Documents

Publication Publication Date Title
JP2007001975A5 (ja)
EP2361930A3 (en) Multimers of MHC-peptide complexes and uses thereof in Borrelia infectious diseases
WO2007060117A3 (de) Chimäre keratinbindende effektorproteine
ATE482721T1 (de) Peptide zur desensibilisierung gegenüber allergenen
JP2007045829A5 (ja)
WO2006094093A3 (en) A method for identifying skin care composition-resistant skin-binding peptides
BRPI0417721A (pt) kit contendo um medicamento farmacêutico, métodos para preparar uma formulação lìquida de um polipeptìdeo de fator de coagulação sangüìnea e para tratar uma sìndrome responsiva a fator de coagulação, uso de um polipeptìdeo de fator vii, composição, e, métodos para preparar as composições e para tratar uma sìndrome responsiva a fvii
JP2007515936A5 (ja)
EP2301959A3 (en) Motif-grafted hybrid polypeptides and uses thereof
WO2008121615A3 (en) Antibody formulation
WO2004084805A3 (en) Acetylated tat polypeptides and methods of use thereof
EP2371865A3 (en) Antibodies that bind human protein tyrosine phosphatase beta (HPTP-ß) and uses thereof
EP2289544A3 (en) Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
EP1772735A3 (en) Protein microarray slide
JP2007525465A5 (ja)
JP2018191647A5 (ja)
WO2013116668A3 (en) Diagnostic peptides for lyme disease
WO2003093307A3 (en) Mycobacterial antigens and uses thereof
WO2008041863A8 (en) Novel genes and polypeptides associated with insecticidal activity
WO2009051823A3 (en) Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof
WO2004083448A3 (en) Molecular differences between species of the m.tuberculosis complex
WO2007077464A3 (en) Chicken virus vaccine and diagnostic
WO2007123906A3 (en) Recombinant antigens for diagnosis and prevention of murine typhus
DE60017229D1 (de) DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
JP2000243389A5 (ja)